These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19094815)

  • 1. [Cardiac arrest in the pediatric population].
    Tavares A; Trigo C; Estrada J
    Acta Med Port; 2008; 21(4):383-6. PubMed ID: 19094815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthesia in a child with newly diagnosed Hypertrophic Cardiomyopathy.
    Kaplanian S; Chambers NA
    Paediatr Anaesth; 2006 Oct; 16(10):1080-3. PubMed ID: 16972841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy.
    Ridjab D; Koch M; Zabel M; Schultheiss HP; Morguet AJ
    Cardiology; 2007; 107(2):81-6. PubMed ID: 16804296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
    Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
    Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypertrophic cardiomyopathy with two episodes of recuperated sudden death. Report of the first implantable defibrillator cardioverter inserted in Chile].
    Zalaquett R; Fajuri A; Irarrázaval MJ; Neghme R; Vergara I; Sacco C; Dubernet J; Corbalán R
    Rev Med Chil; 1994 Oct; 122(10):1171-7. PubMed ID: 7659885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous cardiac arrest in monozygotic twins with hypertrophic cardiomyopathy--is sudden cardiac death genetically pre-programmed?
    Goh CY; Asrar ul Haq M; Mutha V; van Gaal WJ
    BMC Cardiovasc Disord; 2015 Feb; 15():16. PubMed ID: 25885451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].
    Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L
    Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documented exercise-induced cardiac arrest in a paediatric patient with hypertrophic cardiomyopathy.
    Pedrote A; Morales FJ; García-Riesco L; Errazquin F
    Europace; 2006 Jun; 8(6):430-3. PubMed ID: 16687426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
    Maron BJ; Maron MS; Lesser JR; Hauser RG; Haas TS; Harrigan CJ; Appelbaum E; Main ML; Roberts WC
    Am J Cardiol; 2008 Feb; 101(4):544-7. PubMed ID: 18312775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D; Ehlert F; Sherrid M
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death prevented in hypertrophic cardiomyopathy.
    Jayatilleke I; McGuire M; Booth V; Richmond DR; Semsarian C
    Heart Lung Circ; 2003; 12(3):196-8. PubMed ID: 16352133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival after cardiac arrest in hypertrophic cardiomyopathy.
    Maron BJ; Haas TS; Shannon KM; Almquist AK; Hodges JS
    Heart Rhythm; 2009 Jul; 6(7):993-7. PubMed ID: 19497790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden death as a presenting symptom of hypertrophic cardiomyopathy: treatment with an implantable cardioverter defibrillator.
    Talard P; Lévy S; Bonal J; Paganelli F; Bouchiat C; Cellarier G; Dussarat GV
    Pacing Clin Electrophysiol; 1996 Aug; 19(8):1264-7. PubMed ID: 8865227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.